Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/24/2002CA2145969C Transcription factor aprf
12/24/2002CA2086264C Surface complexed lymphotoxin
12/24/2002CA2075878C Cyclic peptides and use thereof
12/24/2002CA2070182C Chimeric immunoglobulin for cd4 receptors
12/24/2002CA2065462C Radiopharmaceutical bacteriostats
12/21/2002CA2390757A1 Method of decreasing fasting sugars and weight gains in diabetic patients
12/19/2002WO2002101232A2 Bace interacting proteins
12/19/2002WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002WO2002101071A2 Cd43:modulators of mast cell degranulation
12/19/2002WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002WO2002101049A2 Interleukin-18 mutants, their production and use
12/19/2002WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002WO2002101047A1 Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities
12/19/2002WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002WO2002101044A2 Brain expressed gene and protein associated with bipolar disorder
12/19/2002WO2002101043A2 Regulation of human ta4 receptor
12/19/2002WO2002101040A1 Human-type anti-blood coagulation factor viii antibody
12/19/2002WO2002101034A1 Leptin-induced gene
12/19/2002WO2002101026A2 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms
12/19/2002WO2002101021A2 Purification of human serum albumin
12/19/2002WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002WO2002101008A2 Intracellular signaling molecules
12/19/2002WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002WO2002101002A2 Identification of snps the hgv-v gene
12/19/2002WO2002100898A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002WO2002100893A1 A novel polypeptide - granin-9.35 and a polynucleotide encoding the same
12/19/2002WO2002100889A1 Novel epitope of human papilloma virus e7 antigen and cd4-positive t cells activated by the epitope
12/19/2002WO2002100888A1 Somatostatin-dopamine chimeric analogs
12/19/2002WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002WO2002100885A2 A penta- or tetrapeptide binding to somatostatin receptors and the use of the same
12/19/2002WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002WO2002100836A2 Compounds, compositions and methods for modulating beta-amyloid production
12/19/2002WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002WO2002100453A1 Crosslinkable macromers
12/19/2002WO2002100445A1 Treatment and composition for wound healing
12/19/2002WO2002100441A2 Method for treatment of vascular regeneration
12/19/2002WO2002100429A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
12/19/2002WO2002100428A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
12/19/2002WO2002100427A1 Liver generation promoter
12/19/2002WO2002100426A1 Bmp binding proteins for use in bone or cartilage regeneration
12/19/2002WO2002100424A1 Antiviral composition incorporating lectins
12/19/2002WO2002100421A1 Low molecular weight components of cartilage, complexes of copper with amino acids or di-peptides; processes for preparation and therapeutic uses thereof
12/19/2002WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002WO2002100390A2 Improved method of treating the syndrome of coronary heart disease risk factors in humans
12/19/2002WO2002100387A1 Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation
12/19/2002WO2002100380A1 Production of hard, dense particles
12/19/2002WO2002100345A2 Vaccines, immunotherapeutics and methods of using the same
12/19/2002WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002WO2002100343A2 N-terminally truncated galectin-3 and antibodies for treating cancer
12/19/2002WO2002100337A2 Antithrombotic thrombin variants
12/19/2002WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002WO2002100331A2 Calcium phosphate delivery vehicles for osteoinductive proteins
12/19/2002WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002WO2002100324A2 Compositions and methods for the repair and construction of bone and other tissue
12/19/2002WO2002100250A2 Wit 3.0, a novel gene to control soft tissue wound healing
12/19/2002WO2002100248A2 Compositions and methods relating to glucose metabolism, weight control, and food intake
12/19/2002WO2002100172A1 Administration of agents via the pept-2 transporter
12/19/2002WO2002100148A2 Treatment or prophylaxis of insulin-producing cell graft rejection
12/19/2002WO2002087604A3 Preparations containing a combination of vitamin e and afamin
12/19/2002WO2002085937A3 Inflammation-specific peptides and the uses thereof
12/19/2002WO2002082904A3 Method of treating or retarding the development of blindness
12/19/2002WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002WO2002080754A3 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002WO2002076388A3 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
12/19/2002WO2002074777A3 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity
12/19/2002WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002WO2002072824A3 Human transient receptor potential channel protein.
12/19/2002WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002066012A3 Amphoteric liposomes and the use thereof
12/19/2002WO2002064780A9 Dna sequences for human tumour suppressor genes
12/19/2002WO2002064025A3 Inhibition of atf2 activity to treat cancer
12/19/2002WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002WO2002061055A3 Methods for regulating the kinase domain of ephb2
12/19/2002WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002WO2002055542A3 Hpv-specific peptides, which block the binding of hpv to the host cell
12/19/2002WO2002050261A3 PROTEINS THAT INTERACT WITH βTRCP
12/19/2002WO2002048353A3 Dna-sequences, which code for an apoptosis signal transduction protein
12/19/2002WO2002044360A3 Modified arginine deiminase
12/19/2002WO2002040512A3 Human beta-defensin-3
12/19/2002WO2002033111A3 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
12/19/2002WO2002028887A3 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
12/19/2002WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002WO2002013847A3 Methods for diagnosis and therapy of hematological and virus-associated malignancies
12/19/2002WO2002012269A3 Pharmaceutical composition comprising an analgesic peptide
12/19/2002WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002WO2002005836A3 Stimulation of bone growth with thrombin peptide derivatives
12/19/2002WO2001092297A3 Regulation of human lgr4-like g protein-coupled receptor
12/19/2002WO2001077331A9 Human trp-like calcium channel protein-2 (tlcc-2)
12/19/2002WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002WO2001073060A9 18221, dual specificity phosphatase and uses thereof
12/19/2002WO2001073026A9 43238, a novel g protein-coupled receptor and uses therefor
12/19/2002WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
1 ... 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 ... 3163